Success in finding new stem cells that can produce insulin… Type 1 diabetes is caused by autoimmune disease that leads to the destruction of insulin producing beta cells in the pancreas. The destruction of beta cells in the pancreas can be treated by transplant of pancreatic beta cells or cadaveric …
Read More »Study Finds Beta Cells Not Completely Lost in Type 1 Patients
Most with long-term diagnosis foud to continue to secrete low levels of insulin… In a large-population based study, researchers used sensitive C-peptide assays to demonstrate that 43-74% people with longstanding (>5 years) type 1 diabetes are microsecretors of endogenous insulin with C-peptide levels. The Scottish researchers measured the occurrence of …
Read More »A Look at Managing Diabetes in the Pregnant Population
Latest ADA Guidelines, published January 2015…
Read More »Type 2 Diabetes Control with GLP-1 Agonist and Basal Insulin Combination
Glucose regulation and weight management are very important factors when treating type 2 diabetes patients… Prior studies have shown that glucagon-like peptide receptor agonist are beneficial not only for better glucose control but also helpful in weight reduction in patients with type 2 diabetes. Other studies and recommendations on type …
Read More »Glucose Tolerance and Diabetes Risk in Schizophrenic Patients
Due to the metabolic effects of antipsychotic medications, glucose control is very important in diabetic patients with schizophrenia… Prior studies have shown that patients with schizophrenia can have higher rates of impaired glucose tolerance, insulin resistance, and increased risk for type 2 diabetes mellitus. Risk for diabetes in schizophrenic patients …
Read More »Apple Watch with Dexcom CGM App
Dexcom is creating an app for the soon-to-be-released Apple Watch to receive and display data from its glucose monitors using their Share technology. The smartwatch, which is due out in April, will display readings as an easy-to-read graph. Dexcom has already created apps for iOS devices including the Follow …
Read More »Practical Diabetes Care, 3rd Ed., Excerpt #2: Management of Inpatient Diabetes Part 1 of 2
David Levy, MD, FRCP INTRODUCTION There has been a recent resurgence of interest in the management of diabetes in hospitalized patients. Guidelines in the USA are well-established, and in the UK the ‘ThinkGlucose’ campaign has highlighted the importance of good diabetes care in hospital. Note that good diabetes care does not …
Read More »Change Language to Combat Feelings of Failure
A patient presented for outpatient diabetes education stating, “I really don’t know why I am here. I know I need to lose weight. I don’t know what else you can tell me.” She was reassured when I told her that there are people who are a perfect weight, exercise regularly, …
Read More »Prevention, Diagnosis, and Treatment of DME, Update, Part 2
With this week’s Homerun Slides, we delve further into the treatment of Diabetic Macular Edema (DME). We look at Macular Laser Therapy and why, although it can be very effective, it isn’t necessarily the best solution available today. Now, with new drugs on the market such as Avastin, Lucentis, and Eylea, …
Read More »Short-term Outcomes Worse with Glyburide for GDM
Glyburide (glibenclamide) should not be used to treat gestational diabetes mellitus (GDM) unless insulin and metformin are unavailable, the authors of a new systematic review and meta-analysis conclude…
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.